A STTR Phase II contract was awarded to Atomic-6 in August, 2021 for $749,858.0 USD from the U.S. Department of Defense and United States Air Force.
Atomic-6’s composites and autoclave manufacturing 1) exponentially reduce manufacturing costs; 2) produce the highest performing composites available in the market; and 3) reduce autoclave cycle times by 98% when compared to existing manufacturing process